{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:16:23Z","timestamp":1780391783719,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02358-4","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:48:23Z","timestamp":1776696503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The diagnostic value of \u2076\u2078Ga-FAPI PET\/CT in patients with suspicious recurrent or metastatic differentiated thyroid cancer: a comparative study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiewei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"3","key":"2358_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Cancer J Clin"},{"key":"2358_CR2","doi-asserted-by":"publisher","unstructured":"Br H, Ek A, Kc B, Gm D, Sj M, Ye N, Gw FP, Am R, Kg SMS, Si S, Ja S, Dl S, Rm S, T., L W. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid: Official J Am Thyroid Association. 2016;26(1). https:\/\/doi.org\/10.1089\/thy.2015.0020.","DOI":"10.1089\/thy.2015.0020"},{"issue":"5","key":"2358_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/jjco\/hyv021","volume":"45","author":"S Shinohara","year":"2015","unstructured":"Shinohara S, Kikuchi M, Suehiro A, Kishimoto I, Harada H, Hino M, Ishihara T. Characteristics and prognosis of patients with thyroglobulin-positive and radioactive iodine whole-body scan-negative differentiated thyroid carcinoma. Jpn J Clin Oncol. 2015;45(5):427\u201332. https:\/\/doi.org\/10.1093\/jjco\/hyv021.","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"2358_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/RLU.0b013e318286827b","volume":"38","author":"E Ozkan","year":"2013","unstructured":"Ozkan E, Aras G, Kucuk NO. Correlation of 18F-FDG PET\/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results. Clin Nucl Med. 2013;38(5):326\u201331. https:\/\/doi.org\/10.1097\/RLU.0b013e318286827b.","journal-title":"Clin Nucl Med"},{"issue":"9","key":"2358_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/RLU.0000000000002193","volume":"43","author":"PM Manohar","year":"2018","unstructured":"Manohar PM, Beesley LJ, Bellile EL, Worden FP, Avram AM. Prognostic Value of FDG-PET\/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer. Clin Nucl Med. 2018;43(9):641\u20137. https:\/\/doi.org\/10.1097\/RLU.0000000000002193.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"2358_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Han C, Wang S, Fang P, Ma Z, Xu L, Yin R. Cancer-associated fibroblasts: An emerging target of anti-cancer immunotherapy. J Hematol Oncol. 2019;12(1):86. https:\/\/doi.org\/10.1186\/s13045-019-0770-1.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"2358_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/biomedicines10030523","volume":"10","author":"L Gilardi","year":"2022","unstructured":"Gilardi L, Air\u00f2 Farulla LS, Demirci E, Clerici I, Omodeo Sal\u00e8 E, Ceci F. Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET. Biomedicines. 2022;10(3):523. https:\/\/doi.org\/10.3390\/biomedicines10030523.","journal-title":"Biomedicines"},{"issue":"6","key":"2358_CR8","doi-asserted-by":"publisher","first-page":"890","DOI":"10.2967\/jnumed.121.262808","volume":"63","author":"L Kessler","year":"2022","unstructured":"Kessler L, Ferdinandus J, Hirmas N, Zarrad F, Nader M, Kersting D, Weber M, Kazek S, Sraieb M, Hamacher R, Lueckerath K, Umutlu L, Fendler WP, Rischpler C. Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2022;63(6):890\u20136. https:\/\/doi.org\/10.2967\/jnumed.121.262808.","journal-title":"J Nuclear Medicine: Official Publication Soc Nuclear Med"},{"issue":"8","key":"2358_CR9","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s00259-022-05758-0","volume":"49","author":"Y Wei","year":"2022","unstructured":"Wei Y, Zheng J, Ma L, Liu X, Xu S, Wang S, Pei J, Cheng K, Yuan S, Yu J. [18F]AlF-NOTA-FAPI-04: FAP-targeting specificity, biodistribution, and PET\/CT imaging of various cancers. Eur J Nucl Med Mol Imaging. 2022;49(8):2761\u201373. https:\/\/doi.org\/10.1007\/s00259-022-05758-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"2358_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00259-022-06067-2","volume":"50","author":"X Mu","year":"2023","unstructured":"Mu X, Huang X, Jiang Z, Li M, Jia L, Lv Z, Fu W, Mao J. [18F]FAPI-42 PET\/CT in differentiated thyroid cancer: Diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2023;50(4):1205\u201315. https:\/\/doi.org\/10.1007\/s00259-022-06067-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2358_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1148\/radiol.212430","volume":"304","author":"H Fu","year":"2022","unstructured":"Fu H, Wu J, Huang J, Sun L, Wu H, Guo W, Qiu S, Chen H. 68Ga Fibroblast Activation Protein Inhibitor PET\/CT in the Detection of Metastatic Thyroid Cancer: Comparison with 18F-FDG PET\/CT. Radiology. 2022;304(2):397\u2013405. https:\/\/doi.org\/10.1148\/radiol.212430.","journal-title":"Radiology"},{"issue":"1","key":"2358_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00259-023-06404-z","volume":"51","author":"S Ballal","year":"2023","unstructured":"Ballal S, Yadav MP, Roesch F, Satapathy S, Moon ES, Martin M, Wakade N, Sheokand P, Tripathi M, Chandekar KR, Agarwal S, Sahoo RK, Rastogi S, Bal C. Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET\/CT in radioiodine-resistant follicular-cell derived thyroid cancers. Eur J Nucl Med Mol Imaging. 2023;51(1):233\u201344. https:\/\/doi.org\/10.1007\/s00259-023-06404-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2358_CR13","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s11307-019-01316-7","volume":"21","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Lee C-H, Lee Y, Youn H, Kang KW, Kwon J, Alavi A, Carlin S, Cheon GJ, Chung J-K. Glucose-6-phosphatase Expression-Mediated [18F]FDG Efflux in Murine Inflammation and Cancer Models. Mol Imaging Biology. 2019;21(5):917\u201325. https:\/\/doi.org\/10.1007\/s11307-019-01316-7.","journal-title":"Mol Imaging Biology"},{"issue":"5\u20136","key":"2358_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD. Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy. Proteomics Clin Appl. 2014;8(5\u20136):454\u201363. https:\/\/doi.org\/10.1002\/prca.201300095.","journal-title":"Proteomics Clin Appl"},{"issue":"6","key":"2358_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, Adeberg S, Rathke H, R\u00f6hrich M, Winter H, Plinkert PK, Marme F, Lang M, Kauczor H-U, J\u00e4ger D, Debus J, Haberkorn U, Giesel FL. 68Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2019;60(6):801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nuclear Medicine: Official Publication Soc Nuclear Med"},{"issue":"4","key":"2358_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1158\/2326-6066.CIR-16-0011","volume":"4","author":"E Pur\u00e9","year":"2016","unstructured":"Pur\u00e9 E, Lo A. Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors? Cancer Immunol Res. 2016;4(4):269\u201378. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0011.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"2358_CR17","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s10238-023-00998-2","volume":"23","author":"L Zhu","year":"2023","unstructured":"Zhu L, Zhang X, Zhang S, Zhang Q, Cao L, Zhang Y, Wang D, Liang X, Wu W, Wu S, Jiang R, Liu Y, Zhao X, Zhou G, Xu K, Meng Z. Cancer-associated fibroblasts in papillary thyroid carcinoma. Clin Experimental Med. 2023;23(6):2209\u201320. https:\/\/doi.org\/10.1007\/s10238-023-00998-2.","journal-title":"Clin Experimental Med"},{"issue":"1","key":"2358_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3413\/nukmed-0489-12-03","volume":"52","author":"B Riemann","year":"2013","unstructured":"Riemann B, Uhrhan K, Dietlein M, Schmidt D, Kuwert T, Dorn R, Sciuk J, Kodalle T, Schober O. Diagnostic value and therapeutic impact of (18)F-FDG-PET\/CT in differentiated thyroid cancer. Results of a German multicentre study. Nuklearmedizin Nuclear Med. 2013;52(1):1\u20136. https:\/\/doi.org\/10.3413\/nukmed-0489-12-03.","journal-title":"Nuklearmedizin Nuclear Med"},{"issue":"5","key":"2358_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/ng.3818","volume":"49","author":"H Li","year":"2017","unstructured":"Li H, Courtois ET, Sengupta D, Tan Y, Chen KH, Goh JJL, Kong SL, Chua C, Hon LK, Tan WS, Wong M, Choi PJ, Wee LJK, Hillmer AM, Tan IB, Robson P, Prabhakar S. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet. 2017;49(5):708\u201318. https:\/\/doi.org\/10.1038\/ng.3818.","journal-title":"Nat Genet"},{"issue":"5","key":"2358_CR20","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.21037\/gs-20-430","volume":"9","author":"FA Rashid","year":"2020","unstructured":"Rashid FA, Munkhdelger J, Fukuoka J, Bychkov A. Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic review. Gland Surg. 2020;9(5):1878\u2013900. https:\/\/doi.org\/10.21037\/gs-20-430.","journal-title":"Gland Surg"},{"key":"2358_CR21","doi-asserted-by":"publisher","first-page":"6562149","DOI":"10.1155\/2022\/6562149","volume":"2022","author":"Z Ye","year":"2022","unstructured":"Ye Z, Xia X, Xu P, Liu W, Wang S, Fan Y, Guo M. The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population. Int J Endocrinol. 2022;2022:6562149. https:\/\/doi.org\/10.1155\/2022\/6562149.","journal-title":"Int J Endocrinol"},{"issue":"12","key":"2358_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/jclinpath-2020-207357","volume":"74","author":"J Ham","year":"2021","unstructured":"Ham J, Wang B, Po JW, Singh A, Niles N, Lee CS. Cancer-associated fibroblasts (CAFs) in thyroid papillary carcinoma: Molecular networks and interactions. J Clin Pathol. 2021;74(12):759\u201365. https:\/\/doi.org\/10.1136\/jclinpath-2020-207357.","journal-title":"J Clin Pathol"},{"issue":"1","key":"2358_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13550-020-0610-x","volume":"10","author":"LH de Vries","year":"2020","unstructured":"de Vries LH, Lodewijk L, Braat AJAT, Krijger GC, Valk GD, Lam MGEH, Rinkes B, Vriens IHM, M. R., de Keizer B. 68Ga-PSMA PET\/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617. EJNMMI Res. 2020;10(1):18. https:\/\/doi.org\/10.1186\/s13550-020-0610-x.","journal-title":"EJNMMI Res"},{"issue":"9","key":"2358_CR24","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.7150\/thno.108676","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Guan L, Zhang X, Li J, Wang X, Li W, Xu L, Liu S, Tang Z, Cui M, Pang H. Dual targeting PET tracer [68Ga]Ga-PSFA-01 in patients with prostate cancers: A pilot exploratory study. Theranostics. 2025;15(9):4124\u201334. https:\/\/doi.org\/10.7150\/thno.108676.","journal-title":"Theranostics"},{"issue":"23","key":"2358_CR25","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1158\/1078-0432.CCR-23-1983","volume":"29","author":"H Fu","year":"2023","unstructured":"Fu H, Huang J, Zhao T, Wang H, Chen Y, Xu W, Pang Y, Guo W, Sun L, Wu H, Xu P, Su B, Zhang J, Chen X, Chen H. Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study. Clin Cancer Research: Official J Am Association Cancer Res. 2023;29(23):4740\u201350. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1983.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02358-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02358-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02358-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:43:24Z","timestamp":1780389804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02358-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02358-4","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol complies with the principles of the Declaration of Helsinki and has been approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (Approval No: 2025-544-01). Written informed consent was obtained from each subject prior to the examination.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}